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Summary Background: No specific data are available in the literature on the
bronchoalveolar lavage (BAL) findings of Legionella pneumophila pneumonia. We
report on the cytological and immunophenotypical BAL data of three immunocom-
petent patients with severe community-acquired pneumonia due to L. pneumophila
serogroup 1.
Methods: Retrospective chart review. The microbiologial diagnosis was obtained
by BAL culture or/and urinary antigen assay.
Results: All patients presented with high-grade fever, bilateral chest infiltrates
and severe respiratory failure requiring ventilatory support. The cytological BAL
pattern at presentation showed in all patients the association of a marked
neutrophilia with a variable but remarkable percentage of lymphoblasts. Increased
levels of activated T-lymphocytes (both HLA-DRþ and CD25þ cells) and, in 2 out of
3 patients, of T-cells bearing the g=d T-cell receptor were the main immunophe-
notypical findings on flow cytometric analysis.
Conclusions: We suggest that the association of lymphoblasts with a marked
neutrophilia in BAL fluid of patients with a clinical-radiological setting compatible
with acute pneumonia should suggest L. pneumophila as a possible etiologic agent.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Legionella pneumophila is considered a common
cause of severe pneumonia requiring admission to
an intensive care unit (ICU), being second only to
bacteremic pneumococcal pneumonia in several
comprehensive studies.1–4
Unfortunately, the clinical findings have been
shown not to be reliable in distinguishing Legionella
infection from other bacterial pneumonias.5 Re-
cently, the urinary antigen testing has been
associated with good sensitivity (80–90%) and very
high specificity (98–100%) in detecting L. pneumo-
phila serogroup 1 infection, although concerns have
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been raised over the sensitivity of this test early in
the course of the disease.6,7 In 17 patients with L.
pneumophila serogroup 1 pneumonia, 5 of 7
patients with a negative urinary antigen test during
the first 5 days of illness had a subsequent positive
test.7 To our knowledge, the literature contains no
specific information on the bronchoalveolar lavage
(BAL) findings in L. pneumophila pneumonia. We
report on the morphological and immunophenoty-
pical BAL findings of 3 patients with severe
community-acquired pneumonia (CAP) due to L.
pneumophila serogroup 1 both at onset and, in the
2 who survived the acute phase, after a 3-month
follow-up.
Methods
The BAL findings of 3 patients diagnosed with
severe CAP due to L. Pneumophila serogroup 1
were collected and retrospectively reviewed to-
gether with the clinical, radiological, and labora-
tory data. For the etiologic diagnosis, either a
positive urinary antigen test or/and a positive BAL
culture for L. Pneumophila serogroup 1 was
required. BAL was performed both at onset and,
in the 2 patients who survived the acute phase, at
3-month follow-up. The BAL protocol that we used
matches the accepted technical recommendations
and guidelines.8 Briefly, the fiberscope was wedged
in a subsegmental bronchus of an affected lung
area as showed by chest-CTand six 25ml aliquots of
sterile saline solution were instilled. Fluid was
gently aspirated immediately after each aliquot
was infused and collected in a sterile container; the
first two aliquots of the recovered BAL were
treated separately. After recovery, BAL fluid was
filtered through a monolayer surgical gauze to
remove mucus and centrifuged at 2000 revolutions/
min for 15min. Cytospin preparations were stained
by both the May–Grunwald–Giemsa and the Papa-
nicolaou methods. An experienced pathologist
performed the differential cell count (under light
microscopy at  1000 by counting 400 cells in
random fields) and the evaluation of cytological
cell characteristics. The total cell count was
obtained by using a hemocytometer. The lympho-
cyte subpopulations were determined with a flow
cytometer after staining with the following mono-
clonal antibodies: CD3 (pan-T-cells), CD4 (T-helper
cells), CD8 (T-suppressor/cytotoxic cells), CD20 (B-
cells), CD25 (lymphocytes expressing interleukin-2
receptors), CD57 (natural killer cells), HLA-DR
(activated T-lymphocytes and B-cells), a=b TCR (T-
lymphocytes bearing the a=b T-cell receptor), and
g=d TCR (T-lymphocytes bearing the g=d T-cell
receptor). The microbiological studies on BAL
included, in all patients, both cultures (for detec-
tion of common bacteria, mycobacteria, fungi, L.
pneumophila, adenovirus, cytomegalovirus, herpes
simplex virus types I and II) and immunofluores-
cence tests (for detection of respiratory syncitial
virus). Furthermore, an accurate search for both
intracytoplasmatic or intranuclear viral inclusions
and for P. Carinii cysts was performed.
Results
The diagnosis of L. Pneumophila pneumonia in the 3
immunocompetent patients of this series was
obtained by urinary antigen assay in one (pt no.
2), and by both BAL culture and urinary antigen
assay in the other two. All of them presented at the
emergency room of Bologna Maggiore Hospital with
high-grade fever, extensive bilateral chest infil-
trates and respiratory failure. One patient (pt no.
1) was initially hospitalized in the internal medicine
ward and then moved to the ICU on the second day
of hospitalization because of rapidly progressive
respiratory failure requiring ventilatory support.
Patient no. 2, who presented with massive hemo-
peritoneum due to spleen rupture requiring emer-
gency splenectomy, was moved to the ICU after
surgery. The remaining patient (pt no. 3) was
immediately admitted to the ICU and submitted
to invasive mechanical ventilation.
The main clinical and outcome data are showed
in Table 1. The only patient (pt no. 1) who is alive
and well did receive anti-Legionella drugs as part of
the antibiotic regimen he received on hospital
admission, before the etiologic diagnosis was
obtained. Patient no. 2 presented with a massive
hemoperitoneumFa finding that has been seldom
described in the setting of legionellosis9Fand
respiratory failure associated with bilateral infil-
trates on admission chest X-ray. This patient
survived the acute phase but developed ventila-
tor-associated pneumonia due to P. aeruginosa 1
month after the initial hospital admission and died
after 5 months of hospitalization due to septic
shock. The remaining patient (pt no. 3) died a few
days after admission of pneumonia-induced refrac-
tory respiratory failure; this patients was the only
current smoker and its initial antibiotic regimen did
not contain anti-Legionella drugs. Laboratory find-
ings at presentation were remarkable, in all
patients, for a marked increase of the white blood
cells, the differential count being characterized by
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a huge neutrophilia and a severe lymphopenia
(Table 1).
All patients showed extensive, bilateral, alveolar
consolidation with air bronchogram on chest-CT
scan.
The BAL-fluid analysis is summarized in Table 2.
The cytological BAL pattern at presentation was
characterized by the association of a marked
neutrophilia along with a variable percentage of
large, activated lymphocytes with blastic features,
exhibiting round or convoluted nuclei with multiple
small nucleoli, and a basophilic cytoplasm (Fig. 1).
Follow-up BAL after anti-Legionella antibiotic
treatment, performed in the 2 patients who
survived the acute phase, showed the reduction
or even the disappearance of lymphoblasts and
neutrophils (Fig. 2).
As far as the immunophenotypical BAL profile is
concerned, a marked increase of activated T-
lymphocytes (both HLA-DRþ and CD25þ cells)
could be detected in all patients at presentation;
curiously, only CD 25þ cells were found to be
markedly reduced on follow-up BAL, whereas
HLA-DRþ cells remained persistently increased.
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Table 1 Clinical features on admission and outcome data.
Pt no. 1 Pt no. 2 Pt no. 3
Age (yr)/sex 71/M 70/M 59/M
Smoking habit Non-smoker Non-smoker 60 pack yr1
Illness durationn
(days)
6 6 1
Comorbidities None Diabetes mellitus Chronic bronchitis
Hypertensive cardiopathy
Clinical presentation Rapidly progressive RF Hemoperitoneum Rapidly progressive RF
High-grade fever (421C) Rapidly progressive RF High-grade fever (401C)
High-grade fever (401C)
WBC (103 dl–1)
On admission 18 (97% N; 1.5% L) 13 (92% N; 3% L) 22 (96% N; 2% L)
After diagnosis 22 (94% N; 2.0% L) 18 (95% N; 2% L) 25 (N 96%; 2% L)
PaO2 (room air)
(mmHg)
35 33 31
Antibiotic treatment
On admission Ceftriaxoneþ clarythromycin Gentamicinþ ciprofloxacin Ceftriaxone
After diagnosis Clarythromycinþ ciprofloxacin Rifampicinþ clarythromycin Rifampicinþ clarythromycin
Outcome Alive and well Died Died
Abbreviations: RF¼ respiratory failure; N¼ neutrophils; L¼ lymphocytes; NP¼ not performed.
nTime interval from onset of symptoms to hospital admission.
Table 2 BAL-fluid analysis at presentation.
Pt
no.
Timingn
(days)
Recovery
(%)
Total
cells
(103ml1)
M
(%)
N
(%)
L
(%)
LB
(%)
E
(%)
PC
(%)
CD4/CD8
(ratio)
Other features
1 11 65 590 16 49 7 22 1 5 3.55 36% of CD3þDRþ lymphocytes
19% of CD3þCD25 lymphocytes
12% of g=d T-lymphocytes
2 10 55 290 9 80 3 7 0 1 1.62 49% of CD3þDRþ lymphocytes
24% of CD3þCD25þ lymphocytes
19% of g=d T-lymphocytes
3 5 50 840 16 68 10 4 2 0 1.12 20% of CD3þDRþ lymphocytes
16% of CD3þCD25þ lymphocytes
Abbreviations: M¼macrophages; N¼ neutrophils; L¼ lymphocytes; LB¼ lymphoblasts; E¼ eosinophils; PC¼plasma cells.
nTime interval from onset of symptoms to BAL.
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Increased T-lymphocytes bearing the g=d T-cell
receptor were detected, only at presentation, in
2 out of 3 patients (Table 2).
All the microbiological studies on the BAL fluid
proved negative, except for the positive culture for
L. Pneumophila serogroup 1 in 2 out of 3 patients
(pt no. 1 and 3).
Discussion
We provide the first thorough description of the
cytological and immunophenotypical BAL findings in
three immunocompetent patients with severe
pneumonia due to L. pneumophila, all of them
infected by the serogroup 1 strain.
Early in the course of the disease, the presence
of a variable percentage of lymphoblasts in
association with a marked neutrophilia was the
cytological hallmark and rendered the BAL profile
of these patients different from the one usually
observed in other bacterial pneumonias, the latter
showing only a pronounced neutrophilia.10,11 It is of
note that lymphoblasts should not be normally
present in BAL fluid. To the best of our knowledge,
a BAL cytology characterized by scattered blasts
and a variable increase of neutrophils had been
only attributed so far to opportunistic pathogens,
especially P. carinii, in several settings of immuno-
depression.12,13 Interestingly, the presence of
lymphoblasts in the setting of Legionella infection
is frequently observed in the blood of both patients
and experimental animals.14–16 Furthermore, a
lymphocyte blastogenic response has been shown
to occur even earlier than the production of
measurable antibodies in 13 patients with acute
legionellosis and has been suggested to be poten-
tially useful to diagnosis.17
The main immunophenotypical BAL findings at
presentation included an increase of both activated
T-lymphocytes (both HLA-DRþ and CD25þ cells)
and, in 2 out of 3 patients, of g=d T-lymphocytes.
Lymphocyte activation with lymphokines produc-
tion is thought to be a key factor for the host
resistance to Legionella infection and occurs in the
blood in the first 2 weeks of infection as part of the
cell-mediated immune response orchestrated by
the host against the organism.14,18 The T-lympho-
cytes bearing the g=d receptor, on the other hand,
are important in the host defence against intracel-
lular pathogens, as members of the Legionellaceae
family are.19,20 In 14 patients with Pontiac fever, a
mild and transient form of intracellular bacterial
disease caused by Legionella micdadei, Kroca and
coworkers noticed an initial depletion of circula-
tory g=d T-cells, followed by a pronounced and
long-lasting expansion.21 The authors hypothesized
that g=d T-cells are initially recruited at the
primary site of infection before they expand in
response to antigen and occur in high numbers in
the blood.21
Overall, the BAL findings at presentation from
our patients suggest, also in the primary site of
infection, the importance of cell-mediated immu-
nity in the setting of Legionella pneumonia.14
Curiously, the patient (pt no. 3) whose BAL fluid
had the lower number of lymphoblasts, the lower
increase of activated T-lymphocytes, and the
absence of g=d T-cells, died a few days after the
onset of the disease. By considering these data, one
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Figure 1 BAL showing several large, activated lympho-
cytes with blastic features (black arrows), along with
numerous neutrophils. A mitotic figure (white arrow) is
also evident (Papanicolaou,  1000).
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Abbreviations: M=macrophages; N= neutrophils; L=lymphocytes; LB=lymphoblasts
Figure 2 BAL changes in differential cell counts in the 2
patients who survived the acute phase.
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could speculate that he developed a less effective
cell-mediated immune response to the organism as
compared to the other two. Nevertheless, the
empiric antibiotic regimen he was submitted to
before the etiologic diagnosis was obtained did not
contain anti-Legionella drugs, a factor that is well
known to negatively affect the outcome in the
setting of Legionella pneumonia.22 Furthermore,
he was a heavy smoker and his respiratory status
could have been markedly impaired even before
Legionella infection, leading to an earlier and more
severe respiratory failure.
In the follow-up BAL, a common tendency
towards the reduction of lymphoblasts, neutro-
phils, and CD25þ T-lymphocytes was evident,
along with a persistent increase of the HLA-DRþ
T-cells (Fig. 2). These similar changes in the BAL
pattern are even more surprising if one considers
the completely different clinical status of the 2
patients at the time they underwent follow-up
bronchoscopy. In fact, one of them was an out-
patient doing well and simply complaining of mild
exertional dyspnea, whereas the other patient (pt
no. 2) had never left the ICU and had developed a
ventilator-associated pneumonia due to Pseudomo-
nas Aeruginosa. Apparently, however, the only
influence of the P. Aeruginosa infection on BAL in
this patient was a less pronounced reduction in the
neutrophils percentage.
In conclusion, our data suggest that a quite
characteristic and homogeneous BAL profile can be
observed in patients with severe pneumonia due to
L. pneumophila serogroup 1. In the appropriate
clinical setting, this data should prompt aggressive
diagnostic search (culture and molecular tests on
respiratory secretions, besides urinary antigen
testing) and empiric anti-Legionella treatment.
We look forward to verifying if the BAL findings
that we observed will be confirmed in larger groups
of patients with L. pneumophila pneumonia.
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